Lista de obras - Georgios Giamas - Dominio Público Uruguay

A revised nomenclature for the lemur family of protein kinases

artículo científico publicado en 2024

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation.

scientific article published on 30 March 2016

Astrocytes, the rising stars of the glioblastoma microenvironment

scientific article published on 21 September 2018

Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer

artículo científico publicado en 2014

CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.

artículo científico publicado en 2009

Cancer Gene Therapy: vision and strategy for the new decade

scientific article published on 18 February 2020

Cancer stem cells—therapeutic targeting or therapy? ⬇️

artículo científico publicado el 1 de junio de 2013

Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin

scientific journal article

Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics.

artículo científico publicado en 2015

Claudin-1 as a promoter of EMT in hepatocellular carcinoma.

artículo científico publicado en 2013

Confirming size-exclusion chromatography as a clinically relevant extracellular vesicles separation method from 1mL plasma through a comprehensive comparison of methods

artículo científico publicado en 2024

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

artículo científico publicado en 2017

Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling.

artículo científico publicado en 2017

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?

artículo científico publicado en 2019

Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.

artículo científico publicado en 2019

Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention.

artículo científico publicado en 2016

Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.

artículo científico publicado en 2014

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.

artículo científico publicado en 2013

KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

artículo científico publicado en 2014

Kinases as targets in the treatment of solid tumors.

scientific article published on 21 January 2010

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.

artículo científico publicado en 2011

Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

artículo científico publicado en 2024

LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer

artículo científico publicado en 2015

LMTK3 confers chemo-resistance in breast cancer.

artículo científico publicado en 2018

LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.

artículo científico publicado en 2015

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.

artículo científico publicado en 2011

LMTK3 is implicated in endocrine resistance via multiple signaling pathways.

artículo científico publicado en 2012

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

artículo científico publicado en 2014

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

artículo científico publicado en 2012

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo

artículo científico publicado en 2012

Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo

artículo científico publicado en 2007

Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States ⬇️

artículo científico publicado el 5 de agosto de 2013

Protein kinases as targets for cancer treatment.

artículo científico publicado en 2007

Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer

artículo científico publicado en 2016

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer.

artículo científico publicado en 2015

Reply: When does a human being die?

scientific article published on 25 September 2015

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1.

artículo científico publicado en 2013

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.

artículo científico publicado en 2018

Strategies in functional proteomics: Unveiling the pathways to precision oncology.

artículo científico publicado en 2016

Targeting lemurs against cancer metastasis

artículo científico publicado en 2014

Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor.

artículo científico publicado en 2015

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

artículo científico publicado en 2009

The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.

artículo científico publicado en 2014

The many-faced KSR1: a tumor suppressor in breast cancer.

artículo científico publicado en 2015

The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer.

artículo científico publicado en 2008

The potential role of cyclooxygenase-2 (COX-2) during early breast cancer therapy

artículo científico publicado en 2011

The role of pseudokinases in cancer.

artículo científico

The structure-function relationship of oncogenic LMTK3

artículo científico publicado en 2020

Three Method-Combination Protocol for Improving Purity of Extracellular Vesicles

artículo científico publicado en 2020

Tumor-Stromal Cell Communication: Small Vesicles Signal Big Changes

artículo científico publicado en 2016

When does a human being die?

artículo científico publicado en 2015

Lista de obras de Georgios Giamas

A revised nomenclature for the lemur family of protein kinases

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation.

Astrocytes, the rising stars of the glioblastoma microenvironment

Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer

CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.

Cancer Gene Therapy: vision and strategy for the new decade

Cancer stem cells—therapeutic targeting or therapy? ⬇️

Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin

Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics.

Claudin-1 as a promoter of EMT in hepatocellular carcinoma.

Confirming size-exclusion chromatography as a clinically relevant extracellular vesicles separation method from 1mL plasma through a comprehensive comparison of methods

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling.

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?

Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.

Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention.

Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.

KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

Kinases as targets in the treatment of solid tumors.

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.

Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer

LMTK3 confers chemo-resistance in breast cancer.

LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.

LMTK3 is implicated in endocrine resistance via multiple signaling pathways.

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo

Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo

Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States ⬇️

Protein kinases as targets for cancer treatment.

Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer.

Reply: When does a human being die?

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1.

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.

Strategies in functional proteomics: Unveiling the pathways to precision oncology.

Targeting lemurs against cancer metastasis

Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor.

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.

The many-faced KSR1: a tumor suppressor in breast cancer.

The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer.

The potential role of cyclooxygenase-2 (COX-2) during early breast cancer therapy

The role of pseudokinases in cancer.

The structure-function relationship of oncogenic LMTK3

Three Method-Combination Protocol for Improving Purity of Extracellular Vesicles

Tumor-Stromal Cell Communication: Small Vesicles Signal Big Changes

When does a human being die?